These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15056579

  • 1. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR.
    Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
    [Abstract] [Full Text] [Related]

  • 2. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.
    Cochrane Database Syst Rev; 2013 Oct 17; 2013(10):CD003196. PubMed ID: 24132760
    [Abstract] [Full Text] [Related]

  • 3. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.
    Health Technol Assess; 2007 Oct 17; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug 17; 14(78):140-2. PubMed ID: 16106596
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A, Rendell JM, Geddes J.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD004367. PubMed ID: 19160237
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.
    Curr Med Res Opin; 2012 May 21; 28(5):701-13. PubMed ID: 22356118
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
    Am J Psychiatry; 2005 Jul 21; 162(7):1281-90. PubMed ID: 15994710
    [Abstract] [Full Text] [Related]

  • 8. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG, Qian H, Keramatian K, Chakrabarty T, Saraf G, Lam RW, Wong H, Yatham LN.
    Aust N Z J Psychiatry; 2020 Mar 21; 54(3):298-307. PubMed ID: 31845587
    [Abstract] [Full Text] [Related]

  • 9. Predictors of relapse or recurrence in bipolar I disorder.
    Degenhardt EK, Gatz JL, Jacob J, Tohen M.
    J Affect Disord; 2012 Feb 21; 136(3):733-9. PubMed ID: 22036802
    [Abstract] [Full Text] [Related]

  • 10. Polytherapy in bipolar disorder.
    Lin D, Mok H, Yatham LN.
    CNS Drugs; 2006 Feb 21; 20(1):29-42. PubMed ID: 16396522
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan 21; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 12. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G, Albert U, Salvi V, Mancini M, Bogetto F.
    J Affect Disord; 2007 Apr 21; 99(1-3):247-51. PubMed ID: 17056122
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.
    Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, Trzepacz PT, Watkin JG, Tohen M.
    Br J Psychiatry; 2004 Dec 21; 185():472-8. PubMed ID: 15572737
    [Abstract] [Full Text] [Related]

  • 14. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H.
    Mol Psychiatry; 2016 Aug 21; 21(8):1050-6. PubMed ID: 26460229
    [Abstract] [Full Text] [Related]

  • 15. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
    Hayes JF, Pitman A, Marston L, Walters K, Geddes JR, King M, Osborn DP.
    JAMA Psychiatry; 2016 Jun 01; 73(6):630-7. PubMed ID: 27167638
    [Abstract] [Full Text] [Related]

  • 16. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
    BALANCE investigators and collaboratorsOxford Clinical Trials Unit for Mental Illness, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK. john.geddes@psych.ox.ac.uk, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E.
    Lancet; 2010 Jan 30; 375(9712):385-95. PubMed ID: 20092882
    [Abstract] [Full Text] [Related]

  • 17. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.
    J Clin Psychiatry; 2006 Jan 30; 67(1):95-101. PubMed ID: 16426094
    [Abstract] [Full Text] [Related]

  • 18. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.
    Am J Psychiatry; 2006 Feb 30; 163(2):247-56. PubMed ID: 16449478
    [Abstract] [Full Text] [Related]

  • 19. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
    Tohen M, Wang WV, Leboyer M, Jen KY.
    J Clin Psychiatry; 2012 Jul 30; 73(7):e913-7. PubMed ID: 22901362
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.